These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 29631022)
21. Oncocytic tumors are marked by enhanced mitochondrial content and mtDNA mutations of complex I in Chinese patients. Lyu L; Wang Q; Song S; Li L; Zhou H; Li M; Jiang Z; Zhou C; Chen G; Lyu J; Bai Y Mitochondrion; 2019 Mar; 45():1-6. PubMed ID: 29386142 [TBL] [Abstract][Full Text] [Related]
22. Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid. Volante M; Bozzalla-Cassione F; DePompa R; Saggiorato E; Bartolazzi A; Orlandi F; Papotti M Virchows Arch; 2004 Aug; 445(2):183-8. PubMed ID: 15252732 [TBL] [Abstract][Full Text] [Related]
23. Two distinct thyroid tumours in a patient with Cowden syndrome carrying both a 10q23 and a mitochondrial DNA germline deletion. Pradella LM; Zuntini R; Magini P; Ceccarelli C; Neri I; Cerasoli S; Graziano C; Gasparre G; Turchetti D J Med Genet; 2011 Nov; 48(11):779-82. PubMed ID: 21926107 [TBL] [Abstract][Full Text] [Related]
24. Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma. Baris O; Mirebeau-Prunier D; Savagner F; Rodien P; Ballester B; Loriod B; Granjeaud S; Guyetant S; Franc B; Houlgatte R; Reynier P; Malthiery Y Oncogene; 2005 Jun; 24(25):4155-61. PubMed ID: 15806164 [TBL] [Abstract][Full Text] [Related]
25. [Correlations between cytology and histology in thyroid pathology. Case 8. Suspicion of oncocytic papillary carcinoma]. Trouette H Ann Pathol; 2009 Apr; 29(2):124-9. PubMed ID: 19364586 [No Abstract] [Full Text] [Related]
26. Cardiolipins Are Biomarkers of Mitochondria-Rich Thyroid Oncocytic Tumors. Zhang J; Yu W; Ryu SW; Lin J; Buentello G; Tibshirani R; Suliburk J; Eberlin LS Cancer Res; 2016 Nov; 76(22):6588-6597. PubMed ID: 27659048 [TBL] [Abstract][Full Text] [Related]
27. A Comprehensive Characterization of Mitochondrial Genome in Papillary Thyroid Cancer. Su X; Wang W; Ruan G; Liang M; Zheng J; Chen Y; Wu H; Fahey TJ; Guan M; Teng L Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27735863 [TBL] [Abstract][Full Text] [Related]
28. Oncocytic lesions of the neuroendocrine system. Canberk S; LiVolsi VA; Baloch Z Adv Anat Pathol; 2014 Mar; 21(2):69-82. PubMed ID: 24508690 [TBL] [Abstract][Full Text] [Related]
29. Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor. Witte J; Lehmann S; Wulfert M; Yang Q; Röher HD World J Surg; 2007 Jan; 31(1):51-9. PubMed ID: 17171498 [TBL] [Abstract][Full Text] [Related]
30. Oncocytic carcinoma of the breast: frequency, morphology and follow-up. Ragazzi M; de Biase D; Betts CM; Farnedi A; Ramadan SS; Tallini G; Reis-Filho JS; Eusebi V Hum Pathol; 2011 Feb; 42(2):166-75. PubMed ID: 21111455 [TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670 [TBL] [Abstract][Full Text] [Related]
32. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Yeh JJ; Lunetta KL; van Orsouw NJ; Moore FD; Mutter GL; Vijg J; Dahia PL; Eng C Oncogene; 2000 Apr; 19(16):2060-6. PubMed ID: 10803467 [TBL] [Abstract][Full Text] [Related]
33. Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors. Tallini G; Ladanyi M; Rosai J; Jhanwar SC Cytogenet Cell Genet; 1994; 66(4):253-9. PubMed ID: 7909283 [TBL] [Abstract][Full Text] [Related]
34. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852 [TBL] [Abstract][Full Text] [Related]
37. Fine-needle aspirations of papillary carcinoma with oncocytic features: an expanded cytologic and histologic profile. Renshaw AA Cancer Cytopathol; 2011 Aug; 119(4):247-53. PubMed ID: 21400667 [TBL] [Abstract][Full Text] [Related]
38. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. Chiappetta G; Toti P; Cetta F; Giuliano A; Pentimalli F; Amendola I; Lazzi S; Monaco M; Mazzuchelli L; Tosi P; Santoro M; Fusco A J Clin Endocrinol Metab; 2002 Jan; 87(1):364-9. PubMed ID: 11788677 [TBL] [Abstract][Full Text] [Related]
39. BRAF mutations are associated with some histological types of papillary thyroid carcinoma. Trovisco V; Vieira de Castro I; Soares P; Máximo V; Silva P; Magalhães J; Abrosimov A; Guiu XM; Sobrinho-Simões M J Pathol; 2004 Feb; 202(2):247-51. PubMed ID: 14743508 [TBL] [Abstract][Full Text] [Related]
40. High-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants. Kurelac I; de Biase D; Calabrese C; Ceccarelli C; Ng CK; Lim R; MacKay A; Weigelt B; Porcelli AM; Reis-Filho JS; Tallini G; Gasparre G Am J Cancer Res; 2015; 5(6):1954-71. PubMed ID: 26269756 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]